title: Phase I study of 21 days continuous infusion with vindesine.
authors.affiliation: Department of Internal Medicine, University Hospital Groningen, The Netherlands.
authors.forename: E G
authors.initials: EG
authors.lastname: de Vries
authors.forename: E F
authors.initials: EF
authors.lastname: Smit
authors.forename: D E
authors.initials: DE
authors.lastname: Vendrig
authors.forename: J J
authors.initials: JJ
authors.lastname: Holthuis
authors.forename: N H
authors.initials: NH
authors.lastname: Mulder
mesh_terms: D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007260:Infusion Pumps; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced; D014751:Vindesine / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D014751:Vindesine